Until Labs
Organ Cryopreservation
2 open roles Organ Cryopreservation San Francisco, United States 37 employees $106M raised Est. 2021
Founders Fund
Lux Capital
Field Ventures
Age 1
Day One Ventures
About Until Labs
Until Labs is developing reversible cryopreservation technology to extend the viability of donor organs for transplantation and enable whole-body medical hibernation.
Until Labs is listed on Rocketlist with 2 active roles. The company is categorized as Organ Cryopreservation in BioTech. Until Labs is at Series A stage, with a B2B business model, headquartered in San Francisco, United States. Until Labs was founded in 2021 and has 37 employees. Until Labs has raised $106M. Active roles are refreshed daily from public hiring sources.